| Literature DB >> 33525692 |
Alessandro De Stefano1, Sabrina Caporali2, Nicola Di Daniele1, Valentina Rovella1, Carmine Cardillo3,4, Francesca Schinzari4, Marilena Minieri5, Massimo Pieri5, Eleonora Candi5,6, Sergio Bernardini5, Manfredi Tesauro1, Alessandro Terrinoni5.
Abstract
Flavonoids display a broad range of structures and are responsible for the major organoleptic characteristics of plant-derived foods and beverages. Recent data showed their activity, and in particular of luteolin-7-O-glucoside (LUT-7G), in reduction of oxidative stress and inflammatory mechanisms in different physiological systems. In this paper, we tried to elucidate how LUT-7G could exert both antioxidant and anti-inflammatory effects in endothelial cells cultured in vitro. Here, we showed that LUT-7G is able to inhibit the STAT3 pathway, to have an antiproliferative action, and an important antioxidant property in HUVEC cells. These properties are exerted by the flavone in endothelial through the transcriptional repression of a number of inflammatory cytokines and their receptors, and by the inhibition of ROS generation. ROS and STAT3 activation has been correlated with the production of oxysterols and other hydroxylated fatty acids, and they have been recognized important as players of atherogenesis and cardiocirculatory system diseases. The analysis of the general production pathway of these hydroxylated species, showed a strong decrease of cholesterol hydroxylated species such as 7-alpha-hydroxicholesterol, 7-beta-hydroxicholesterol by the treatment with LUT-7G. This confirms the anti-inflammatory properties of LUT-7G also in the endothelial district, showing for the first time the molecular pathway that verify previous postulated cardiovascular benefits of this flavone.Entities:
Keywords: STAT3; flavonoids; hydroxylation; inflammation; luteolin-7-O-glucoside
Mesh:
Substances:
Year: 2021 PMID: 33525692 PMCID: PMC7865871 DOI: 10.3390/ijms22031321
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 6.208